Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Kangpu initiates first-in-human study of KPG-818 for SLE

May 23, 2019

Sustained efficacy seen with zilucoplan in phase II study in patients with myasthenia gravis

May 21, 2019

Japanese researchers patent RyR1 channel blockers

May 20, 2019

BNTA promotes generation of extracellular matrix components and delays osteoarthritis progression

May 20, 2019

Phase I study of Sc-rAAV2.5IL-1Ra in moderate knee OA now enrolling participants

May 6, 2019

Samumed launches phase III clinical program for lorecivivint in knee osteoarthritis

May 3, 2019

New therapeutic protein reduces B-cell signaling

May 3, 2019

Pericytes rebuild muscle mass

May 3, 2019

FDA approves etanercept biosimilar Eticovo

April 30, 2019

FDA approves intravenous Benlysta for pediatric SLE

April 29, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...